Johnson Matthey Fine Chemicals provides an extensive range of APIs in addition to our broad portfolio of controlled substances
We have specific expertise in high potency cytotoxics including platinum-based oncology actives, high purity cannabidiols and prostaglandins. Moreover our products cover a wide range of therapeutic classes such as anti-cancer, anti-rheumatic, addiction, psychiatric disorders and ophthalmic indications.
We are continually looking to expand and increase our API portfolio through collaborative working – a core principle at Johnson Matthey Fine Chemicals. Our APIs & Life Cycle Management partnership offering combines flexible and innovative business models with collaborative process development to strengthen your products, while reducing your risk.